|
Volumn 2, Issue 6, 2013, Pages
|
A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACYLCARNITINE;
BIOLOGICAL MARKER;
CARNITINE;
CARNITINE OLEATE;
DRUG DERIVATIVE;
AGED;
ARTICLE;
BLOOD;
CARDIOVASCULAR DISEASE;
CASE CONTROL STUDY;
CHI SQUARE DISTRIBUTION;
CHRONIC KIDNEY FAILURE;
DIALYSIS;
FEMALE;
HUMAN;
LIQUID CHROMATOGRAPHY;
MALE;
MASS SPECTROMETRY;
METABOLISM;
METABOLOMICS;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTIVARIATE ANALYSIS;
PROSPECTIVE STUDY;
RENAL REPLACEMENT THERAPY;
RISK;
RISK FACTOR;
STATISTICAL MODEL;
TIME;
TREATMENT OUTCOME;
UREMIA;
VERY ELDERLY;
CARDIOVASCULAR DISEASE;
DIALYSIS;
METABOLISM;
MORTALITY;
RISK FACTORS;
AGED;
AGED, 80 AND OVER;
BIOLOGICAL MARKERS;
CARDIOVASCULAR DISEASES;
CARNITINE;
CASE-CONTROL STUDIES;
CHI-SQUARE DISTRIBUTION;
CHROMATOGRAPHY, LIQUID;
FEMALE;
HUMANS;
KIDNEY FAILURE, CHRONIC;
LOGISTIC MODELS;
MALE;
MASS SPECTROMETRY;
METABOLOMICS;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
ODDS RATIO;
PROSPECTIVE STUDIES;
RENAL DIALYSIS;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
UREMIA;
|
EID: 84900555268
PISSN: None
EISSN: 20479980
Source Type: Journal
DOI: 10.1161/JAHA.113.000542 Document Type: Article |
Times cited : (111)
|
References (0)
|